Synopsis of recent research by authors named "Neil Munro"
- Neil Munro's recent research primarily focuses on the efficacy and applicability of sodium-glucose co-transporter-2 (SGLT2) inhibitors and other diabetes therapies in real-world settings, investigating their effectiveness in managing chronic kidney disease and heart failure among diverse patient populations.
- His work includes systematic reviews and cohort studies that assess the representativeness of clinical trial populations compared to real-world patients, particularly examining the effects of SGLT2 inhibitors in individuals without type 2 diabetes and evaluating glycemic control's impact on cardiovascular outcomes.
- Additionally, Munro addresses barriers to initiating injectable therapies for type 2 diabetes and explores the regulatory landscape affecting diabetes management, highlighting the importance of tailored treatment approaches in primary care settings.
